Deutsche Bank backs AtaiBeckley in the Psychedelic Renaissance, citing drugs BPL-003, VLS-01 and EMP-01 and projecting multibillion dollar sales after FDA approval.
Deutsche Bank backs AtaiBeckley in the Psychedelic Renaissance, citing drugs BPL-003, VLS-01 and EMP-01 and projecting multibillion dollar sales after FDA approval.